14.01.20|Adi Pick EarlySign combines machine-learning technology and decades-worth of electronic health records (EHR) to create an artificial intelligence-based disease risk predictor
11.12.19|Lilach BaumerThe researchers behind Jerusalem-based BiondVax talked to Calcalist, discussing their potential universal flu vaccine, currently undergoing a phase 3 clinical trial